title: Primary biliary cirrhosis clinical research single-topic conference.
authors.affiliation: Mayo Foundation, Rochester, MN 55905, USA.
authors.forename: K D
authors.initials: KD
authors.lastname: Lindor
authors.forename: J
authors.initials: J
authors.lastname: Hoofnagle
authors.forename: W C
authors.initials: WC
authors.lastname: Maddrey
authors.forename: I E
authors.initials: IE
authors.lastname: Mackay
authors.forename: E R
authors.initials: ER
authors.lastname: Dickson
mesh_terms: D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); D001324:Autoantigens / Q000276:immunology; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007658:Ketone Oxidoreductases / Q000276:immunology; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy / Q000201:enzymology / Q000276:immunology; D008727:Methotrexate / Q000627:therapeutic use; D009097:Multienzyme Complexes / Q000276:immunology; D012106:Research; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
chemical_list: D001324:Autoantigens; D002756:Cholagogues and Choleretics; D007166:Immunosuppressive Agents; D009097:Multienzyme Complexes; D014580:Ursodeoxycholic Acid; D007658:Ketone Oxidoreductases; D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); D008727:Methotrexate